Please select a video from the list below.
Prostanoids in Pediatric PAH
While IV epoprostenol remains the gold standard for the treatment of advanced pediatric PAH, newer agents may be initiated in carefully selected patients. Dr. Erika Berman Rosenzweig of Columbia University, reviews the use of prostanoids in pediatric PAH patients. Recorded at the UCSF 9th Annual Neonatal and Childhood Pulmonary Vascular Disease Conference.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 785
ICU Management of PH
ICU Management of PH Views - 124
Animal Models of PH
Animal Models of PH Views - 64
Holding Court in PAH
Holding Court in PAH Views - 1597
 CTEPH Basics
CTEPH Basics Views - 71
The INFORM Study
The INFORM Study Views - 401